BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11840039)

  • 1. Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
    Kaufman SS; Lyden ER; Brown CR; Davis CK; Andersen DA; Olsen KM; Bergman KL; Horslen SP; Sudan DL; Fox IJ; Shaw BW; Langnas AN
    J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):194-8. PubMed ID: 11840039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
    Balaban DH; Duckworth CW; Peura DA
    Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of nasogastric omeprazole suspension in pediatric intensive care patients.
    Haizlip JA; Lugo RA; Cash JJ; Vernon DD
    Pediatr Crit Care Med; 2005 Mar; 6(2):182-7. PubMed ID: 15730606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients.
    Tsai WL; Poon SK; Yu HK; Chang CS; Yeh HZ; Ko CW; Chen GH
    Aliment Pharmacol Ther; 2000 Jan; 14(1):123-7. PubMed ID: 10632655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
    Javsicas LH; Sanchez LC
    Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
    Otani Y; Kitajima M; Sugiyama M; Watanabe Y; Aoki T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S22-6. PubMed ID: 7594333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.
    Faure C; Michaud L; Shaghaghi EK; Popon M; Turck D; Navarro J; Jacqz-Aigrain E
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):144-8. PubMed ID: 11568514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress.
    Lenz K; Buder R; Firlinger F; Lohr G; Voglmayr M
    Wien Klin Wochenschr; 2015 Jan; 127(1-2):51-6. PubMed ID: 25409944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 0.5 mg/kg versus 1 mg/kg of intravenous omeprazole for the prophylaxis of gastrointestinal bleeding in critically ill children: a randomized study.
    Solana MJ; López-Herce J; Sánchez A; Sánchez C; Urbano J; López D; Carrillo A
    J Pediatr; 2013 Apr; 162(4):776-782.e1. PubMed ID: 23149178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole.
    Yildizdas D; Yapicioglu H; Yilmaz HL
    J Crit Care; 2002 Dec; 17(4):240-5. PubMed ID: 12501151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
    Castell D
    Expert Opin Pharmacother; 2005 Nov; 6(14):2501-10. PubMed ID: 16259581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed-Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects.
    Kim KN; Yang SW; Kim H; Kwak SS; Kim YS; Cho DY
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):53-58. PubMed ID: 28111929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.
    Merritt AM; Sanchez LC; Burrow JA; Church M; Ludzia S
    Equine Vet J; 2003 Nov; 35(7):691-5. PubMed ID: 14649361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intragastric pH on control of peptic ulcer bleeding.
    Li Y; Sha W; Nie Y; Wu H; She Q; Dai S; Jia L; Yu W
    J Gastroenterol Hepatol; 2000 Feb; 15(2):148-54. PubMed ID: 10735538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
    Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
    J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
    Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
    Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.